Literature DB >> 1794373

In vitro activity of the new glycopeptide LY264826 versus vancomycin against clinical isolates of enterococci.

C Watanakunakorn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1794373     DOI： 10.1007/BF02005460

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  3 in total

1.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

2.  In vitro activity of LY 264826 compared with that of vancomycin against 100 clinical isolates each of methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Authors:  E L Fasola; J A Moody; D N Gerding; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

3.  In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.

Authors:  K V Rolston; H Nguyen; M Messer
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.